Abstract
One of the main risk factors for the development of an autoimmune disease is to be a woman. Much attention has been given to the involvement of female hormones in their etiology and sexual bias, although the mechanisms behind this potentially strong contribution in disease susceptibility are poorly understood. ABHD6 gene was recently identified as a risk factor for system lupus erythematosus and the risk was correlated with overexpression of the gene. ABHD6 is an enzyme that degrades the 2-arachidonoylglycerol, an endocannabinoid with immunomodulatory effects. Thus its degradation could contribute to immune dysregulation and development of autoimmune reactions. Sex hormones, such as estrogens, are believed to regulate important genes in the endocannabinoid pathway. However, no study was available regarding the effect of these hormones in human immune cells. In this study, ABHD6 expression was evaluated by quantitative PCR in leukocytes from healthy male and females and in the presence of estrogen or progesterone (PG). A statistical increase in ABHD6 expression could be detected in women. In the presence of estrogen or PG, a statistical upregulation of ABHD6 was observed, and in a sex-dependent manner, as only female cells responded to stimulation. Our results suggest that female hormones can promote the overexpression of ABHD6 in immune cells. This can potentially contribute to a pro-inflammatory scenario and partially explain the association of this gene in the development of LES, a highly female-biased disease.
Similar content being viewed by others
References
Asaba J, Bandyopadhyay M, Kindy M, Dasgupta S (2015) Estrogen receptor signal in regulation of B cell activation during diverse immune responses. Int J Biochem Cell Biol 68:42–47. https://doi.org/10.1016/j.biocel.2015.08.012
Ayakannu T, Taylor AH, Marczylo TH et al (2013) The endocannabinoid system and sex steroid hormone-dependent cancers. Int J Endocrinol. https://doi.org/10.1155/2013/259676
Bernardi G, Centonze D, Finazzi-agro A, Maccarrone M (2007) The endocannabinoid system in targeting inflammatory neurodegenerative diseases. https://doi.org/10.1016/j.tips.2007.02.004
Bouman A, Jan Heineman M, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411–423. https://doi.org/10.1093/humupd/dmi008
Bourdeau V, Deschênes J, Métivier R et al (2004) Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol Endocrinol 18:1411–1427. https://doi.org/10.1210/me.2003-0441
Boverhof DR, Burgoon LD, Williams KJ, Zacharewski TR (2008) Inhibition of estrogen-mediated uterine gene expression responses by dioxin. 82–93. https://doi.org/10.1124/mol.107.040451
Butts CL, Bowers E, Horn JC et al (2008) Inhibitory effects of progesterone differ in dendritic cells from female and male rodents. Gend Med 5:434–447. https://doi.org/10.3816/clm.2009.n.003.novel
Chapman KD (2000) Emerging physiological roles for N-acylphosphatidylethanolamine metabolism in plants: signal transduction and membrane protection. Chem Phys Lipids 108:221–229
Driscoll MD, Sathya G, Muyan M et al (1998) Sequence requirements for estrogen receptor binding to estrogen response elements. J Biol Chem 273:29321–29330. https://doi.org/10.1074/jbc.273.45.29321
Fine PG, Rosenfeld MJ (2013) The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Med J 4:e0022. https://doi.org/10.5041/rmmj.10129
Fisette A, Tobin S, Fulton S, Alquier T (2016) Report a/b—hydrolase domain 6 in the ventromedial hypothalamus controls energy. Metabolism. https://doi.org/10.1016/j.celrep.2016.10.004
Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 62:155–198. https://doi.org/10.1124/pr.109.002071
Hughes GC (2012) Progesterone and autoimmune disease. Autoimmun Rev 11:1–28. https://doi.org/10.1016/j.autrev.2011.12.003.progesterone
Katchan V, David P, Shoenfeld Y (2016) Cannabinoids and autoimmune diseases: a systematic review. Autoimmun Rev 15:513–528. https://doi.org/10.1016/j.autrev.2016.02.008
Lettre G, Rioux JD (2008) Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 17:116–121. https://doi.org/10.1093/hmg/ddn246
Lockshin MD (2006) Sex differences in autoimmune disease. Orthop Clin N Am 37:629–633. https://doi.org/10.1016/j.ocl.2006.08.002
Lone RO, Frith MC, Karlsson EK, Hansen U (2004) Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18:1859–1875. https://doi.org/10.1210/me.2003-0044
Luetjens CM, Didolkar A, Kliesch S et al (2006) Tissue expression of the nuclear progesterone receptor in male non-human primates and men. J Endocrinol 189:529–539. https://doi.org/10.1677/joe.1.06348
Maresz K, Pryce G, Ponomarev ED et al (2007) Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB 1 on neurons and CB 2 on autoreactive T cells. 13:492–497. https://doi.org/10.1038/nm1561
Marino M, Galluzzo P, Ascenzi P (2006) Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics 7:497–508
Nagarkatti P, Pandey R, Rieder SA et al (2009) Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 1:1333–1349. https://doi.org/10.4155/fmc.09.93.cannabinoids
Nebel D, Jönsson D, Norderyd O et al (2010) Differential regulation of chemokine expression by estrogen in human periodontal ligament cells. J Periodontal Res 45:796–802. https://doi.org/10.1111/j.1600-0765.2010.01308.x
Oparina NY, Delgado-vega AM, Martinez-bueno M et al (2014) PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6. 1–9. https://doi.org/10.1136/annrheumdis-2013-204909
Pauklin S, Petersen-Mahrt SK (2009) Progesterone inhibits activation-induced deaminase by binding to the promoter. J Immunol 183:1238–1244. https://doi.org/10.4049/jimmunol.0803915
Pennell LM, Galligan CL, Fish EN (2012) Sex affects immunity. J Autoimmun 38:J282–J291. https://doi.org/10.1016/j.jaut.2011.11.013
Pierdominici M, Maselli A, Colasanti T et al (2010) Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett 132:79–85. https://doi.org/10.1016/j.imlet.2010.06.003
Rubtsov AV, Rubtsova K, Kappler JW, Marrack P (2010) Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 9:494–498. https://doi.org/10.1016/j.autrev.2010.02.008
Schwartzman-Morris J, Putterman C (2012) Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol. https://doi.org/10.1155/2012/604892
Seki T, Namba T, Mochizuki H, Onodera M (2007) Clustering, migration, and neurite formation of neural precursor cells in the adult rat hippocampus. J Comp Neurol 502:275–290. https://doi.org/10.1002/cne
Shen H, Panchanathan R, Rajavelu P et al (2010) Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. J Mol Cell Biol 2:284–290. https://doi.org/10.1093/jmcb/mjq023
Sipe JC, Arbour N, Gerber A, Beutler E (2005) Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism : possible risk for autoimmune disorders Abstract : immune system responsiveness results from numerous factors, including endogenous can. 78:231–238. https://doi.org/10.1189/jlb.0205111.introduction
Tan IJ, Peeva E, Zandman-Goddard G (2014) Hormonal modulation of the immune system—a spotlight on the role of progestogens. Autoimmun Rev 14:536–542. https://doi.org/10.1016/j.autrev.2015.02.004
Ueda N, Tsuboi K, Uyama T, Ohnishi T (2011) Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. 1–7. https://doi.org/10.1002/biof.131
Vrtačnik P, Ostanek B, Mencej-Bedrač S, Marc J (2014) The many faces of estrogen signaling. Biochem Med 24:329–342. https://doi.org/10.11613/bm.2014.035
Wen J, Ribeiro R, Tanaka M, Zhang Y (2015) Neuropharmacology activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis. Neuropharmacology 99:196–209. https://doi.org/10.1016/j.neuropharm.2015.07.010
Whitacre CC (2001) Sex differences in autoimmune disease. Nat Immunol 2:777–780. https://doi.org/10.1038/ni0901-777
Yahata T, Shao W, Endoh H et al (2001) Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev 15:2598–2612. https://doi.org/10.1101/gad.906301
Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6:366–372. https://doi.org/10.1016/j.autrev.2006.10.001
Zurier RB, Rossetti RG, Lane JH et al (1998) Dimethylheptyl-thc-11 oic acid. Arthritis Rheum 41:163–170
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior). Grant Number 23038.008120/2010-11.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Rights and permissions
About this article
Cite this article
Drehmer, M.N., Muniz, Y.C.N., Marrero, A.R. et al. Gene Expression of ABHD6, a Key Factor in the Endocannabinoid System, Can Be Modulated by Female Hormones in Human Immune Cells. Biochem Genet 57, 35–45 (2019). https://doi.org/10.1007/s10528-018-9871-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-018-9871-8